BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

AcroMetrix Announces Launch of PeliSpy Chagas Positive Control


11/6/2007 11:03:09 AM

BENICIA, Calif., Nov. 6 /PRNewswire/ -- AcroMetrix announced today the launch of the PeliSpy Chagas Positive Control. This external run control is intended to provide the laboratory a means of estimating precision and reproducibility of assays that detect antibodies to the Trypanosoma cruzi (T. cruzi) parasite, the cause of Chagas disease.

Chagas disease is a potentially deadly infection which often does not exhibit symptoms for up to 40 years. It is now endemic to most of Central and South America, with an increasing number of new cases reported in the US every year. Some experts estimate as many as 100,000 legal immigrants to the US and Canada are unknowingly infected with T. cruzi. The parasite may be spread through contact with insect feces, congenital transmission, organ transplantation, or blood transfusion.

Routine use of the PeliSpy Chagas Positive external run control can help laboratories to monitor the day-to-day performance of their Chagas assay, including consistency between reagent lots and operator variation. PeliSpy Chagas Positive Controls are packaged ready-to-use and are developed to closely mimic an actual patient sample. This product is for Research Use Only. Not for use in diagnostic procedures.

About AcroMetrix

AcroMetrix, with facilities in Benicia, California and Alkmaar, the Netherlands, provides a comprehensive line of molecular and serological diagnostic quality control products that assist laboratories in meeting current government regulations regarding quality. AcroMetrix maintains this leadership role by consistently developing innovative standards, external run controls, and validation kits for molecular and serological testing in blood screening and clinical diagnostic laboratories. For more information on AcroMetrix please visit the company web site at http://www.acrometrix.com.

CONTACT: Alexis Stimpfle of AcroMetrix, +1-707-746-8888, ext. 144, or fax,
+1-707-746-8881, ams@acrometrix.com

Web site: http://www.acrometrix.com/



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->